Grabar Law Office File’s Suit on Behalf of the City of St. Louis Against Major Insulin Manufacturers and PBMs
By Grabar Law |
January 13, 2026 – Philadelphia, PA – Grabar Law Office has filed a major federal lawsuit in the U.S. District ...
Read More 
Grabar Law Office Files Suit on Behalf of WashU Against Major Insulin Manufacturers and PBMs
By Grabar Law |
January 13, 2026 – Philadelphia, PA – Grabar Law Office has filed a major federal lawsuit in the U.S. District ...
Read More 
Grabar Law Office Files Federal Antitrust Class Action Challenging Alleged Price-Fixing by PepsiCo and Walmart
By Grabar Law |
Philadelphia, PA - December 23, 2025 - Grabar Law Office announced today that it has filed a federal antitrust class ...
Read More 
Grabar Law Office Files Suit on Behalf of The City of Charlotte Against Major Insulin Manufacturers and PBMs
By Grabar Law |
Grabar Law Office and Hausfeld LLP today announced the filing of a major federal lawsuit in the U.S. District Court ...
Read More 
Grabar Law Office In The News: Fiber Optics Co. Agrees To Reforms To End Derivative Suit
By Grabar Law |
Fiber optic equipment company Luna Innovations Inc. has reached a deal with its investors to settle their derivative claims alleging ...
Read More 
Grabar Law Office In the News:Â Â Alto Neuroscience Execs Sued Over Rosy Drug Claims
By Grabar Law |
An Alto Neuroscience investor claims CEO Amit Etkin and other directors overstated the efficacy of the psychiatric biotech company's lead ...
Read More 
Grabar Law Office In the News:Â Â Marijuana Vape Antitrust Actions Consolidated In Calif.
By Grabar Law |
Five proposed antitrust class actions brought by buyers of CCell brand cannabis vape accusing the Chinese manufacturers and U.S. distributors ...
Read More 
Grabar Law Office In the News:Â Â DOJ Asks for Stay in PVC Antitrust Case Amid Criminal Probe
By Grabar Law |
The U.S. Department of Justice is asking an Illinois federal court to pause discovery in a case accusing polyvinyl chloride ...
Read More 
Grabar Law Office In the News: Biotech Replimune Faces Derivative Suit Over Trial Claims
By Grabar Law |
Executives and directors of biotechnology company Replimune Group Inc. face shareholder derivative claims that they concealed issues affecting a clinical ...
Read More 
Grabar Law Office Files Federal Lawsuit Against Major Insulin Manufacturers and PBMs on Behalf of the University of Pennsylvania
By Grabar Law |
Grabar Law Office has filed a complaint on behalf of The Trustees of the University of Pennsylvania in the United ...
Read More